α-Conotoxin AuIB TFA is a potent and selective α3β4 nicotinic acetylcholine receptor (nAChR) antagonist that blocks α3β4 nAChRs expressed in African clawed toad oocytes with an IC50 of 0.75 μM.
α-Conotoxin GI TFA is a short peptide toxin isolated from the venom of Conus geographus that has a high affinity for nAChR. α-Conotoxin GI TFA has similar activity to neuromuscular blocking agents.
α-Conotoxin GI TFA is a short peptide toxin isolated from the venom of Conus geographus that has a high affinity for nAChR. α-Conotoxin GI TFA has similar activity to neuromuscular blocking agents.
α-Conotoxin MII TFA, a natural product isolated from the sea snail Conus magus, can effectively inhibit the α3β2 subunit of the nAChR receptor, with an IC50 value of 0.5 nM. In addition, α-Conotoxin MII TFA can effectively inhibit the activity of β3-containing neuro-nicotinic receptor.
α-Conotoxin MII TFA, a natural product isolated from the sea snail Conus magus, can effectively inhibit the α3β2 subunit of the nAChR receptor, with an IC50 value of 0.5 nM. In addition, α-Conotoxin MII TFA can effectively inhibit the activity of β3-containing neuro-nicotinic receptor.
α-Conotoxin PIA TFA is a nicotinic acetylcholine receptor (nAChR) antagonist that targets the nAChR, which contains both the α6 and α3 subunits. α-Conotoxin PIA TFA can be used in studies related to Parkinson's disease and schizophrenia.
α-Conotoxin PIA TFA is a nicotinic acetylcholine receptor (nAChR) antagonist that targets the nAChR, which contains both the α6 and α3 subunits. α-Conotoxin PIA TFA can be used in studies related to Parkinson's disease and schizophrenia.
α-Cyano-4-hydroxycinnamic acid (α-CHCA) is a potent and non-competitive inhibitor of monocarboxylate transporters (MCTs). α-Cyano-4-hydroxycinnamic acid inhibits mitochondrial pyruvate transporter with a Ki of 6.3 μM.
α-Cyano-4-hydroxycinnamic acid (α-CHCA) is a potent and non-competitive inhibitor of monocarboxylate transporters (MCTs). α-Cyano-4-hydroxycinnamic acid inhibits mitochondrial pyruvate transporter with a Ki of 6.3 μM.
α-Cyano-4-hydroxycinnamic acid (α-CHCA) is a potent and non-competitive inhibitor of monocarboxylate transporters (MCTs). α-Cyano-4-hydroxycinnamic acid inhibits mitochondrial pyruvate transporter with a Ki of 6.3 μM.
α-CD has a smaller cavity size than β-CD, so it is more suitable for inclusion of small molecules in inclusions, and applications that require high CD solubility.
α-CD has a smaller cavity size than β-CD, so it is more suitable for inclusion of small molecules in inclusions, and applications that require high CD solubility.